欧洲硬皮病活动指数在早期硬皮病队列中的预测价值
本研究基于加拿大硬皮病研究组数据库中197例病程≤3年且基线无终末期器官损害的SSc患者,评估EScSG-AI对后续器官损害风险的预测作用。结果显示,在dcSSc中,调整平均EScSG-AI是3年内疾病进展最一致的预测指标,可预测肺功能下降、内脏病变严重度及HAQ-DI恶化,且预测效力超过mRSS。
要点
- 调整平均EScSG-AI可预测dcSSc患者3年内新发严重度评分(Δ≥1)及肺功能显著下降。
- 在多变量分析中,肺病进展仅由调整平均EScSG-AI预测。
- EScSG-AI对健康状态评估的预测效力超过改良Rodnan皮肤评分(mRSS)。
核心结论
- 以调整平均EScSG-AI量化的疾病活动负荷可预测dcSSc患者健康状态恶化和严重器官受累的风险。
- EScSG-AI重复评估并取平均值时反应性更佳。
研究设计与样本
- 来自加拿大硬皮病研究组数据库的421例SSc患者中,纳入197例病程≤3年、基线无终末期器官损害证据且有3年随访数据的患者。
- 疾病活动度采用EScSG-AI评估,并计算两种变异性指标:调整平均EScSG-AI(观察期内EScSG-AI曲线下面积)和持续活动性疾病/ flare。
- 结局基于Medsger严重度评分,包括总体及器官系统内新发严重度评分(Δ≥1)或健康状态显著恶化。
主要发现
- 在dcSSc中,调整平均EScSG-AI是3年内多项研究结局最一致的预测指标:任何主要内脏器官Δ≥1的疾病进展、用力肺活量和一氧化碳弥散量显著下降、内脏疾病严重度及HAQ残疾指数恶化。
- 多变量分析中,肺病进展仅由调整平均EScSG-AI预测,而肺病严重度由调整平均EScSG-AI、年龄较大、mRSS和初始严重度预测。
- EScSG-AI与患者和医生评估的健康状态指标相关,且在预测疾病结局方面优于mRSS。
关键数值与推荐
- 调整平均EScSG-AI为观察期内EScSG-AI的曲线下面积;持续活动性疾病/ flare为另一变异性指标。
- 结局新发严重度评分定义为Δ≥1。
- 疾病进展定义为任何主要内脏器官Δ≥1。
临床怎么用
- 对早期dcSSc患者可重复评估EScSG-AI并取调整平均值,以量化疾病活动负荷并预测器官损害风险。
- EScSG-AI在预测疾病结局方面优于mRSS,可作为评估疾病活动的补充工具。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To estimate the effect of disease activity, as measured by the European Scleroderma Research Group Activity Index (EScSG-AI), on the risk of subsequent organ damage in a large systemic sclerosis (SSc) cohort. METHODS: Of 421 SSc patients from the Canadian Scleroderma Research Group database with disease duration of ⩽ 3 years, 197 who had no evidence of end-stage organ damage initially and available 3 year follow-up were included. Disease activity was assessed by the EScSG-AI with two variability measures: the adjusted mean EScSG-AI (the area under the curve of the EScSG-AI over the observation period) and persistently active disease/flare. Outcomes were based on the Medsger severity scale and included accrual of a new severity score (Δ ⩾ 1) overall and within organ systems or reaching a significant level of deterioration in health status. RESULTS: After adjustment for covariates, the adjusted mean EScSG-AI was the most consistent predictor of risk across the study outcomes over 3 years in dcSSc: disease progression defined as Δ ⩾ 1 in any major internal organ, significant decline in forced vital capacity and diffusing capacity of carbon monoxide, severity of visceral disease and HAQ Disability Index worsening. In multivariate analysis, progression of lung disease was predicted solely by adjusted mean EScSG-AI, while the severity of lung disease was predicted the adjusted mean EScSG-AI, older age, modified Rodnan skin score (mRSS) and initial severity. The EScSG-AI was associated with patient- and physician-assessed measures of health status and overpowered the mRSS in predicting disease outcomes. CONCLUSION: Disease activity burden quantified with the adjusted mean EScSG-AI predicted the risk of deterioration in health status and severe organ involvement in dcSSc. The EScSG-AI is more responsive when done repeatedly and averaged.
引用
- Nevskaya T, Baron M, Pope JE, et al. Predictive value of European Scleroderma Group Activity Index in an early scleroderma cohort. Rheumatology (Oxford). 2017. PMID: 28340090. doi:10.1093/rheumatology/kex015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。